Affiliation:
1. Institute of Chemical Biology and Fundamental Medicine SB RAS, 630090 Novosibirsk, Russia
Abstract
Extracellular vesicles (EVs) are membrane vesicles released into the extracellular milieu by cells of various origins. They contain different biological cargoes, protecting them from degradation by environmental factors. There is an opinion that EVs have a number of advantages over synthetic carriers, creating new opportunities for drug delivery. In this review, we discuss the ability of EVs to function as carriers for therapeutic nucleic acids (tNAs), challenges associated with the use of such carriers in vivo, and various strategies for tNA loading into EVs.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference309 articles.
1. Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles;Bost;ACS Nano,2021
2. Therapeutic Oligonucleotides: State of the Art;Smith;Annu. Rev. Pharmacol. Toxicol.,2019
3. CRISPR-Cas: A tool for cancer research and therapeutics. Nature reviews;Yin;Clin. Oncol.,2019
4. The revival of CpG oligonucleotide-based cancer immunotherapies;Adamus;Contemp. Oncol.,2018
5. Anti-miRNA oligonucleotides: A comprehensive guide for design;Lima;RNA Biol.,2018
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献